Substituted imidazopyridines and imidazopyrimidines, and their use to treat, ameliorate and/or prevent retinal degeneration
The present disclosure provides a method of treating, ameliorating and/or preventing retinal degeneration in a subject, such as, but not limited to, anterior segment of the eye disease and/or age-related macular degeneration (AMD). In certain embodiments, the methods comprise administering to the su...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
18.02.2025
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present disclosure provides a method of treating, ameliorating and/or preventing retinal degeneration in a subject, such as, but not limited to, anterior segment of the eye disease and/or age-related macular degeneration (AMD). In certain embodiments, the methods comprise administering to the subject a therapeutically effective amount of a compound of the disclosure. In certain embodiments, the compounds of the present disclosure prevent and/or minimize cellular attacks, such as oxidative stress-related cellular attacks, and/or promote cell survival.
本公开提供了一种治疗、改善和/或预防受试者视网膜变性的方法,诸如但不限于眼前段疾病和/或年龄相关性黄斑变性(AMD)。在某些实施方式中,该方法包括向受试者施用治疗有效量的本公开化合物。在某些实施方式中,本公开的化合物防止和/或最小化细胞攻击,如氧化应激相关的细胞攻击,和/或促进细胞存活。 |
---|---|
Bibliography: | Application Number: CN20238050874 |